The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...

A study published on Sept. 17 in PLOS Pathogens reports results from a clinical trial of an histone deacetylases (HDAC) inhibitor that had shown potential in preclinical studies and answers open ...

The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have ...

Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent." In this state, they are largely invisible and unassailable. As long as ...

The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree ...

More than 40 million people worldwide are living with HIV-1, which continues to be a major global health challenge due to its ability to persist silently within immune cells, evading complete ...

A new clinical trial suggests that a combination of the drug vorinostat and immunotherapy can coax HIV-infected cells out of latency and attack them. The findings highlight how close -- yet still far ...

Due to the 4-hour maturation half-life of the Timer protein's blue-to-red chromophore, we can detect reactivated or recently silenced proviruses with high sensitivity using Timer fluorescence.

A clinical trial of a new method to activate and kill HIV in the body shows small success, but it's not yet a cure. When you purchase through links on our site, we may earn an affiliate commission.

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...